by admin | Sep 4, 2025 | The Doctor's Dose
Lowe’s CEO Marvin Ellison Prepares for Housing Rebound Sept 4, 2025 • Based on Barron’s interview with Marvin Ellison Overview Lowe’s CEO Marvin Ellison is positioning the company to seize growth when U.S. housing demand rebounds. Despite today’s sluggish home...
by ADRIAN MANZ | Sep 4, 2025 | The Doctor's Dose
Broadcom Beats, Lands a New AI Customer — What It Means for Traders At a Glance Fiscal Q3 Revenue $15.95B (beat) Adj. EPS $1.69 (beat) Q4 Revenue Guide $17.4B (above consensus) AI Revenue Trend +63% YoY to ~$5.2B in Q3; mgmt sees further Q4 growth Stock Action Closed...
by ADRIAN MANZ | Sep 4, 2025 | The Doctor's Dose
CDC Shake-Up Puts Vaccine Trades in Play Washington’s overhaul of the nation’s public-health apparatus is no longer background noise—it’s a live catalyst for vaccine names. This piece explains how CDC turmoil and vaccine stocks intersect with trading tactics you can...
by admin | Sep 4, 2025 | The Doctor's Dose
Figma earnings miss: What traders need to know now Figma’s first report as a public company came in hot on revenue growth—but cool on expectations—sending shares sharply lower after hours. Below is the fast read for day-traders and swing-traders, followed by deeper...
by ADRIAN MANZ | Sep 3, 2025 | The Doctor's Dose
Alphabet antitrust ruling sends shares to a record high A federal judge issued targeted remedies in the Google search case—no breakup, no ban on default-search payments—fueling a sharp rally in Alphabet and a relief pop in Apple. Updated September 3, 2025 Alphabet...
by ADRIAN MANZ | Sep 3, 2025 | The Doctor's Dose
Trump Administration Locks Intel Into Foundry Business with Equity Stake The Trump administration has taken the unusual step of converting $8.9 billion in Chips Act manufacturing grants into a direct 10 per cent equity stake in Intel, a move designed to keep the...
by ADRIAN MANZ | Sep 2, 2025 | The Doctor's Dose
Global End of De Minimis: Understanding U.S. tariffs on small packages The U.S. has begun charging duties on all inbound parcels—regardless of value—after suspending the long-standing de minimis waiver. Here’s what changed, why it happened, and how it affects...
by ADRIAN MANZ | Aug 30, 2025 | The Doctor's Dose
Call Walls & Put Walls: The Options Market’s Hidden Support and Resistance How options positioning boxes price, why walls cause reversals, and how to trade the breakouts. Options walls can “box in” prices: a call wall (resistance) is positioned above, and a put...
by ADRIAN MANZ | Aug 29, 2025 | The Doctor's Dose
Spirit Airlines Bankruptcy: What’s Behind the Troubles and Can It Recover? A look at the latest Chapter 11 filing, the causes of the crisis, and the airline’s chances of recovery. Only months after emerging from restructuring, Spirit Airlines bankruptcy headlines are...
by ADRIAN MANZ | Aug 28, 2025 | The Doctor's Dose
Tesla European Sales Slide 34%, Yet Shares Rise on AI Momentum New data shows that Tesla’s European sales dropped sharply in July 2025, but investor enthusiasm surrounding AI and robo-taxi innovation continues to buoy the stock. Here’s what that means for...
